H2 Equity Partners is pleased to announce that it has signed a definitive agreement for the sale of its shareholding in Optegra Eye Health Care

H2 Equity Partners (“H2”) is pleased to announce that it has signed a definitive agreement for the sale of its shareholding in Optegra Eye Health Care (“Optegra” or the “Company”) to MidEuropa  (“MidEuropa”), a leading private equity firm with a strong track record in building and exiting national and regional leaders in healthcare. The transaction will complete following regulatory clearance. As part of the transaction, H2  will become a minority investor alongside management who will continue to lead the Company.

Optegra offers a wide range of eye care procedures including cataract, AMD, and vision correction for both public and private patients. The company operates 29 highly integrated state-of-the art facilities and performs more than 100k surgical procedures per year with a focus on industry-leading clinical outcomes and outstanding patient experience.

H2 acquired a majority stake in 2021 and has invested significant capital to accelerate its growth. Alongside  the Optegra management team, H2 supported substantial growth and development of the business, opening four UK hospitals, acquiring two bolt-on acquisitions and completed an acquisition in a new territory, Slovakia. As a result revenues and profitability experienced strong growth cementing Optegra as one of the leading ophthalmology groups in Europe.

The Company plans to grow into new geographies and deepen its presence in existing markets through greenfield site development and acquisitions, with a focus on maintaining its industry-leading clinical outcomes and outstanding patient experience.

Eversheds Sutherland (Legal), PWC (Financial), Grant Thornton (Tax), Diligize (IT), Mansfield (Commercial) and Lincoln International (Corporate Finance) acted as exclusive advisors to Optegra and its shareholders. 

Henry Stevens

Senior Associate

 

Henry joined H2 in 2024 and is involved in both evaluating new investment opportunities and supporting existing portfolio companies.

 

Prior to joining H2, Henry spent nearly six years at the strategy consultancy firm, Roland Berger, where he was a core member of the Transaction & Investor Services platform supporting private equity and strategic investors across the Industrial and Regulated & Infrastructure sectors predominantly within the mid-market.

 

Henry graduated from the University of Cambridge with a Bachelor (Hons) in Economics. His interests outside of work are road cycling where he competes in time trials, running and skiing.

Terry Musson

The Amberon Group is a market leading traffic management provider to the utilities and Local Authority markets. Amberon was established in May 2002 with our first depot in Paignton, South West England. Our founding core principles remain at the heart of everything that we do and our continued desire to achieve our purpose; to provide the best service in the Traffic Management sector. This has been the foundation for our success and has cemented our position as the market leader in TM.

During the initial transaction we never felt under any pressure & instantly recognised we would become part of the family. H2 took the time to listen to our views & business strategy, it was obvious from the very beginning that they would be the perfect partner for us.

The guys at H2 have enabled us to continue the momentum & have provided the expertise & knowledge to help us continue on the journey to constantly improve our service offering.

Working with H2 during the last 2 years has given us additional support not just financially but the advice & expertise has helped analytically & strategically.

The ambition and the drive H2 have is extremely infectious & continues to assist the group to overachieve.

It’s enormously reassuring to know H2 will always be at the end of the phone to offer advice but heartening to know they have the trust in us to deliver.